Nandrolone Decanoate 50 mg
| Composition | Nandrolone Decanoate 50 mg |
|---|---|
| Packing | 1ml Amp & Dispo |
| MRP | ₹ 155 |
| Dosage Form | Injections |
Ziabol-50 Injection contains Nandrolone Decanoate 50 mg, the higher-strength formulation of the long-acting anabolic steroid used medically for conditions involving significant muscle wasting, anaemia related to chronic kidney disease, and certain bone disorders. The increased dose is prescribed by doctors when a stronger anabolic effect is required.
Available from Biozia Lifesciences, Ziabol-50 is prescribed strictly for legitimate medical indications under specialist supervision, ensuring patients with conditions like renal anaemia or severe catabolic states receive adequate therapeutic support.
This medicine is commonly used for:
Indicated for anaemia of chronic renal failure (including dialysis patients), aplastic anaemia, and anaemias secondary to malignancy or cytotoxic therapy. Prescribed as adjunctive therapy in severe osteoporosis in postmenopausal women, severe catabolic states, and selected cases of disseminated breast carcinoma in postmenopausal women as palliative therapy. The 50 mg dose is used where a more robust anabolic response is required under specialist supervision.
Ziabol-50 delivers a higher dose of Nandrolone Decanoate to provide stronger support for body tissue building and red blood cell production. It mimics the body's natural anabolic hormones to help muscles recover and grow, encourage the bone marrow to produce more haemoglobin-rich red blood cells, and improve bone strength. The decanoate formulation releases the active medicine slowly from the injection site over several weeks.
Nandrolone Decanoate undergoes enzymatic hydrolysis at the intramuscular depot site, releasing nandrolone, which binds with high affinity to androgen receptors in target tissues. At 50 mg dosing, the prolonged anabolic effect is achieved through sustained receptor activation promoting positive nitrogen balance, increased protein synthesis, and inhibition of glucocorticoid-induced catabolism. Erythropoiesis is stimulated via enhanced renal and extrarenal erythropoietin synthesis. Nandrolone's low propensity for hepatotoxicity compared to 17-alpha-alkylated anabolic steroids is attributed to its non-alkylated structure.
In patients with chronic kidney disease, nandrolone decanoate has been studied as a way to improve haemoglobin levels and reduce the dependence on erythropoiesis-stimulating agents (ESAs), offering an alternative approach to managing renal anaemia.
Ziabol-50 Injection is given as a deep intramuscular injection by a healthcare professional in a clinical setting. The dosing interval (typically every 2 to 4 weeks) and total duration of treatment are prescribed by your doctor based on your medical condition and response to therapy.
Always follow the dosage and schedule advised by your doctor — this is general guidance only.
Possible side effects include acne, oily skin, increased hair growth, fluid retention, and changes in libido. Women may experience virilising effects (voice changes, increased facial or body hair) which may be irreversible if not reported early. Lipid profile changes may occur. Tell your doctor if any side effect is severe or persistent.
Higher doses of anabolic steroids always produce better results.
In medical use, the dose is carefully calibrated to the therapeutic need. Higher doses increase the risk of side effects without necessarily improving outcomes beyond a clinical threshold.
Anabolic steroids damage the liver in all forms.
Injectable nandrolone decanoate is not 17-alpha-alkylated and is significantly less hepatotoxic than oral anabolic steroids. However, liver function should still be monitored during therapy.